Alcon AG
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
26.74%
Market Cap
27.01 Bil.
P/E Ratio
38.41
Dividend Yield
0.44 %
Earnings per Share
1.77 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 94.91 Bil. | 31.13 Bil. | 23.29 | +27.43 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 55.42 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:56:34 PM | |
| DAILY VOLUME (UNITS) | 384 | |
| DAILY HIGH / LOW | 55.68 | 55.1 |
| PREV. DAY'S PRICE | 55.28 | (06/02) |
| CHANGE DAY BEFORE | +0.14 | 0.25 % |
| 52 WEEK HIGH / LOW | 79.16 (07/30) | 52.26 (05/12) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 3.39 | 2.96 | 1.77 | 1.90 | 1.83 |
| DIVIDENDS PER SHARE | 0.34 | 0.30 | 0.30 | 0.29 | 0.25 |
| DIVIDEND YIELD IN % | - | - | 0.44 % | 0.36 % | 0.37 % |
| DIVIDEND GROWTH IN % | - | - | 1.82 % | 19.00 % | 18.07 % |
| PRICE - EARNINGS RATIO | 16.87 | 19.33 | 38.41 | 42.39 | 36.97 |
| PRICE - BOOK RATIO | - | - | 1.77 | 1.95 | 1.87 |
| PRICE - SALES RATIO | - | - | 3.64 | 4.38 | 3.84 |
| PRICE - CASH FLOW RATIO | - | - | 16.68 | 20.91 | 26.13 |
Master Data
| WKN | A2PDXE |
| ISIN | CH0432492467 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | ALCON AG NAM. SF -,04 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Swiss Franc |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 487.40 Mil. |
| MARKET CAPITALISATION | 27.01 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -4.95 % | -12.81 % | -23.63 % | -18.68 % | -26.74 % | - | - | -18.87 % |
| HIGH | 58.86 | 63.78 | 72.38 | 74.64 | 79.16 | - | - | 74.64 |
| LOW | 55.28 | 52.26 | 52.26 | 52.26 | 52.26 | - | - | 52.26 |
Dividend
per share
Company profile
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.
Structured products for Alcon AG
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.